Medical Condition News

RSS

Firefighting chemicals leave brain cancer-linked mutations, study shows

Firefighters show higher rates of glioma-linked SBS42 mutational signatures associated with haloalkane exposure, suggesting occupational risk. The study highlights a clear link between firefighting, chemical exposure, and brain cancer mutations.

13 Mar 2025

New flexible hearing aid offers non-invasive solution for conductive hearing loss

A study from researchers at Wake Forest University School of Medicine highlights a new approach in addressing conductive hearing loss. A team of scientists, led by Mohammad J. Moghimi, Ph.D., assistant professor of biomedical engineering, designed a new type of hearing aid that not only improves hearing but also offers a safe, non-invasive alternative to implantable devices and corrective surgeries.

13 Mar 2025

Struggling with weight? Eat more legumes, cut red meat, and skip soda

Diets rich in whole grains, nuts, legumes, and fruits help reduce obesity risk, while red meat and sugary drinks increase it. Researchers reviewed global evidence to identify which foods support or hinder weight management.

13 Mar 2025

Study shows how autism-linked picky eating causes serious vitamin deficiencies

Children with autism spectrum disorder (ASD) face a high risk of multiple micronutrient deficiencies, especially vitamins A, D, B12, and calcium, due to extreme food selectivity. These deficiencies can lead to severe health issues like rickets, vision loss, and immune dysfunction, even in children with normal body weight.

13 Mar 2025

How gut health shapes heart disease risk — and what you can do about it

A new review highlights how gut microbiome imbalances contribute to cardiovascular disease by altering short-chain fatty acids, TMAO, and inflammatory pathways. The study emphasizes the potential of prebiotics, probiotics, and dietary changes to restore gut health and reduce heart disease risk.

13 Mar 2025

Targeting MARCO enhances cancer immunotherapy effectiveness

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO.

13 Mar 2025

Already approved drug avapritinib shows promise in treating high-grade gliomas

High-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, incidence of recurrence and difficulty for drugs to cross the blood-brain barrier.

13 Mar 2025

Proteins identified as key players in immunotherapy resistance for colorectal cancer

A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with metastatic colorectal cancer.

13 Mar 2025

Combination immunotherapy improves treatment response for head and neck cancer

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs) found that patients responded better to a combination of two immunotherapies than patients who received just one immunotherapy drug.

13 Mar 2025

Portable system detects mild cognitive impairment in older adults

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes.

13 Mar 2025

Study uncovers new insights into pain pathways linked with temporomandibular joint disorders

A groundbreaking study has uncovered new insights into the pain pathways associated with temporomandibular joint (TMJ) disorders.

13 Mar 2025

Promising drug enhances motor recovery after spinal cord injury

Spinal cord injury (SCI)-a condition that leads to partial or complete paralysis-has a profound impact on millions of individuals globally.

13 Mar 2025

Diterpenes show promise in regenerating neurons after brain injury

Researchers from the University of Seville and the University of Cadiz, coordinated by the professors of Physiology Pedro Núñez-Abades and Carmen Castro, have demonstrated that the use of diterpenes facilitates repopulation with new neurons in brain regions damaged by traumatic injuries.

13 Mar 2025

Researchers develop new compound to treat alopecia areata

A research group, led by Dr. Pavel Majer from IOCB Prague, in collaboration with the laboratories of Barbara Slusher and Louis Garza at Johns Hopkins University, have developed a compound that could potentially treat the autoimmune disorder alopecia areata, which causes hair loss leading to the formation of bald patches.

13 Mar 2025

How is academic achievement linked to wellbeing?

This comprehensive study explores the connection between anxiety, cognitive function, and academic success, advocating for holistic educational strategies.

13 Mar 2025

Night shifts and sleep debt linked to higher infection risk in nurses

Researchers determine how sleep duration, sleep debt, and shift work impact the risk of infections among Norwegian nurses.

13 Mar 2025

Clinical trial tests herpes virus-based therapy for neurogenic bladder in people with spinal cord injury

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann.

12 Mar 2025

IgE antibodies show promise in targeting HER2 cancers resistant to other therapies

Antibody treatment which activates the patient's own immune system against cancer, known as immunotherapy, is increasingly being investigated as an alternative for chemotherapy and radiotherapy.

12 Mar 2025

Concussions in college athletes lead to brain changes lasting a year

For college athletes with concussion, brain changes may remain visible in brain scans up to a year after they are cleared to return to play, according to a study published on March 12, 2025, online in Neurology, the medical journal of the American Academy of Neurology.

12 Mar 2025

Four new institutions join BD² Integrated Network to improve bipolar disorder care

Today, Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) announced four new national institutions to receive $2.3 million each to join the BD² Integrated Network, a collaborative research and clinical care model that will improve care, interventions, and outcomes for people living with bipolar disorder.

12 Mar 2025